1.
Integrated Safety Analysis of Ruxolitinib Cream: Data From 20 Clinical Studies in Inflammatory Dermatologic Conditions. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 May 2];9(6):s711. Available from: https://skin.dermsquared.com/skin/article/view/3809